iRhythm Technologies Inc (NAS:IRTC)
$ 91.5 -1.11 (-1.2%) Market Cap: 2.85 Bil Enterprise Value: 3.05 Bil PE Ratio: 0 PB Ratio: 31.90 GF Score: 79/100

iRhythm Technologies Inc at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 04:55PM GMT
Release Date Price: $72.62 (-2.61%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

All right, so let's go ahead and get started. My name is David Lewis, Medical Device Analyst at Morgan Stanley. It's my pleasure to have with us here a couple of members of management of iRhythm, both Kevin King, the CEO; and Matt Garrett, the CFO. We're going to dispense with any preamble, unless you want to give one.

Kevin M. King
iRhythm Technologies, Inc. - President, CEO & Director

No.

Questions & Answers

David Ryan Lewis;Kevin M. King
Morgan Stanley, Research Division - MD;iRhythm

Straight into Q&A. I just want to remind people, as I have all day long, just go to Morgan Stanley research disclosure website and look at fun, fancy facts about me.

Kevin, I want to start with the action from last week, frankly, which is kind of 2-part nature, equity raise and Verily collaboration. Two things I want to talk about is what does Verily do for you and why was this the right time to raise money?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot